{
    "id": "correct_subsidiary_00058_0",
    "rank": 59,
    "data": {
        "url": "https://www.foundersuite.com/investors/lawrence-fritz",
        "read_more_link": "",
        "language": "en",
        "title": "Investor profile",
        "top_image": "https://foundersuite.com/assets/foundersuite/og-image.png",
        "meta_img": "https://foundersuite.com/assets/foundersuite/og-image.png",
        "images": [
            "https://foundersuite-investors-prod.s3.amazonaws.com/investor/image/82933/v1456288519-ljjy0eibne8wwxvbncxh.jpg?X-Amz-Expires=600&X-Amz-Date=20240725T131123Z&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIAIZ2R2RXCG7MVSJMA/20240725/us-east-1/s3/aws4_request&X-Amz-SignedHeaders=host&X-Amz-Signature=26347e10f66f899267730e6e3fed79a90ed12d71ce134599d1dbede9e4272348",
            "https://www.foundersuite.com/blurred/avatar4.png",
            "https://www.foundersuite.com/blurred/avatar0.png",
            "https://www.foundersuite.com/blurred/avatar2.png",
            "https://www.foundersuite.com/blurred/avatar3.png",
            "https://www.foundersuite.com/blurred/avatar1.png",
            "https://www.foundersuite.com/blurred/avatar5.png"
        ],
        "movies": [],
        "keywords": [],
        "meta_keywords": [
            ""
        ],
        "tags": null,
        "authors": [],
        "publish_date": null,
        "summary": "",
        "meta_description": "Software for raising venture capital and managing investor relations. Used by startups, investors, accelerators and financial intermediaries.",
        "meta_lang": "en",
        "meta_favicon": "/assets/foundersuite/apple-touch-icon.png",
        "meta_site_name": "",
        "canonical_link": "https://foundersuite.com",
        "text": "Lawrence C. Fritz is a successful biotechnology entrepreneur with over 25 years of experience in the industry. Prior to joining Auspex he was Founder, President and CEO of Covella Pharmaceuticals, a company focused on inflammatory diseases. Covella was acquired in 2010 by Santarus, Inc. Prior to Covella, he founded Conforma Therapeutics and served as its President and CEO from inception through its acquisition by Biogen Idec in 2006. Conforma focused on the discovery and development of novel small-molecule drugs for cancer therapy. Fritz was also a founder and Director of Cabrellis Pharmaceuticals, a specialty pharma cancer company spun-out from Conforma; Cabrellis was subsequently acquired by Pharmion Corporation. Prior to Conforma, Fritz co-founded both Athena Neurosciences, now wholly-owned by Elan Corporation, and Idun Pharmaceuticals, subsequently acquired by Pfizer. In addition to his work in private biotechnology companies, Fritz served as President and CEO of Anadys Pharmaceuticals, a NASDAQ-listed public company developing drugs for viral diseases and oncology. Fritz is also an Entrepreneur-in-Residence with the venture capital firm Thomas, McNerney & Partners. He holds an A.B. in Biochemical Sciences from Harvard, an M.Sc. in Physiology from University College London, and a Ph.D. in Biophysics from The Rockefeller University."
    }
}